Volume 36 Issue 6
Nov.  2020
Turn off MathJax
Article Contents
Article Navigation >  Journal of Nanjing University of traditional Chinese Medicine  > 2020  >  36(6): 826-830
ZHOUXi, ZHANGDan, QIANHai-hua, ZENGLi. Clinical Study of Xiaoai Jiedu Decoction in the Treatment of Postoperative Colon Cancer[J]. Journal of Nanjing University of traditional Chinese Medicine, 2020, 36(6): 826-830.
Citation: ZHOUXi, ZHANGDan, QIANHai-hua, ZENGLi. Clinical Study of Xiaoai Jiedu Decoction in the Treatment of Postoperative Colon Cancer[J]. Journal of Nanjing University of traditional Chinese Medicine, 2020, 36(6): 826-830.
shu

Clinical Study of Xiaoai Jiedu Decoction in the Treatment of Postoperative Colon Cancer

  • 1.

    The First School of Clinical Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China

  • 2.

    The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029, China

  • Publish Date: 2020-11-10
    Abstract
  • OBJECTIVE To observe the effects of Xiaoai Jiedu Decoction on the quality of life and side effects of chemotherapy in patients with colorectal cancer after surgery. METHODS Inpatients with colorectal cancer in the Anorectal Department， Affiliated Hospital of Nanjing University of Chinese Medicine were selected and single-blind randomly divided into the control group and the treatment group with 30 cases each. The control group received postoperative tumor chemotherapy and psychological intervention， and the treatment group was treated with Xiaoai Jiedu Decoction based on the treatment of the control group. After 12 weeks of treatment， the psychological status， quality of life， levels of peripheral blood cells， immunoglobulin， inflammatory factors， and liver function damage were detected in the two groups. RESULTS After treatment， partial mental state factors， Karnofsky scores in the treatment group were improved， and better than those in the control group (P<0.05，P<0.01). Besides， the peripheral blood cell levels showed no significant change in the treatment group， better than those in the control group (P<0.05，P<0.01). The inflammatory factor levels of interleukin 1β (IL-1β) and tumor necrosis factor-α (TNF-α) notably decreased (P<0.01)， better than the control group (P<0.01). The liver damage levels in the treatment group were better than those in the control group (P<0.05). CONCLUSION Xiaoai Jiedu Decoction can improve the mental state and quality of life of patients with colorectal cancer after surgery as well as reduce the adverse effects of chemotherapy.

     

    • FullText(HTML)
  • loading
    • References(28)
  • [1]
    SIEGEL RL，TORRE LA，SOERJOMATARAM I，et al. Global patterns and trends in colorectal cancer incidence in young adults[J]. Gut， 2019， 68(12):2179-2185.
    [2]
    WANG W，DONG Z，ZHANG X，et al. Dietary and the risk of sporadic colorectal cancer in China: A case-control study[J]. Iran J Public Health， 2018， 47(9):1327-1335.
    [3]
    XU H，ZHU Y，DAI B，et al. National Comprehensive Cancer Network (NCCN) risk classification in predicting biochemical recurrence after radical prostatectomy: A retrospective cohort study in Chinese prostate cancer patients[J]. Asian J Androl， 2018， 20(6):551-554.
    [4]
    谢守泳. 自拟中药汤剂改善乳腺癌化疗抑郁状态及骨髓抑制临床分析[J]. 四川中医，2016， 34(6):115-118.
    [5]
    张新昌. 卡培他滨联用滋补汤对一线化疗后气血两虚证晚期结直肠癌治疗的效果[J]. 慢性病学杂志， 2020， 21(6):859-860.
    [6]
    韩淳淳. 消癌解毒方治疗肝癌20例临床观察及调控人肝癌SMMC-7721细胞miRNA表达的研究[D]. 南京：南京中医药大学， 2016.
    [7]
    陈海彬，周红光，程海波，等. 消癌解毒方对中晚期恶性肿瘤患者免疫功能的影响[J]. 南京医科大学学报(自然科学版)， 2009， 29(9):1257-1259.
    [8]
    中国结直肠癌诊疗规范(2015版)[J]. 中华普通外科学文献(电子版)， 2015， 9(6): 506-523.
    [9]
    刘爱武，李玉山. 大肠癌化疗方案选择[J]. 山东医药， 2001(4):54.
    [10]
    王丽婧，黄风静. 心理干预护理对于直肠癌术后化疗情绪及生活质量的影响[J]. 心理月刊， 2020， 15(12):81.
    [11]
    李茂娟. 分析心理干预护理对于直肠癌术后化疗情绪及生活质量的影响[J]. 智慧健康， 2019， 5(25):124-125.
    [12]
    骆素萍. 大学新生实施SCL-90测查的纵向分析与对策[J]. 福建工程学院学报， 2019， 17(5):505-510.
    [13]
    杨菊英，姚建琴，王祖晶，等. KPS评分与营养水平对肿瘤患者压力性损伤发生的影响[J]. 中西医结合护理(中英文)， 2018， 4(9):23-25.
    [14]
    黄治虎. 还原型谷胱甘肽对恶性肿瘤化疗后肝损伤的疗效观察[J]. 临床医药文献电子杂志， 2014， 1(10):1699-1701.
    [15]
    丁建华，汤巧云，孙萍，等. 晚期非小细胞肺癌患者化疗后肝损伤164例临床分析[J]. 肿瘤研究与临床， 2015， 27(1):39-43.
    [16]
    中华医学会外科学会. 门静脉高压症肝脏功能分级试行标准（1983年，武汉）[J].肝胆胰脾外科杂志， 1995(1):17-18.
    [17]
    李卫强，赵仁，杨治花，等. 益气养阴基本方对直肠癌放疗后气阴两虚证患者的疗效及其免疫功能的影响[J]. 辽宁中医杂志， 2011， 38(4):687-689.
    [18]
    王珊珊. 周仲瑛教授从痰瘀热毒辨治肺癌的临床经验及益肺解毒汤的抗肿瘤实验研究[D]. 南京：南京中医药大学，2017.
    [19]
    程海波，吴勉华. 周仲瑛教授“癌毒”学术思想探析[J]. 中华中医药杂志， 2010， 25(6):866-869.
    [20]
    刘拥军. 消癌解毒Ⅲ号方联合化疗对晚期胃热阴虚型胃腺癌的临床研究[D]. 南京：南京中医药大学， 2017.
    [21]
    丁艳. 消癌解毒方联合放疗治疗痰瘀郁毒气阴两虚型食管癌的临床观察及对血清miRNA的影响[D]. 南京:南京中医药大学， 2019.
    [22]
    陆培华. 消癌解毒方中白花蛇舌草抑制结肠癌的作用及机制研究[D]. 南京：南京中医药大学， 2016.
    [23]
    闵思明，赵晓瑶，陈赛红，等. 太子参参须多糖对免疫抑制小鼠的免疫调节作用研究[J]. 动物医学进展， 2020， 41(8):23-28.
    [24]
    范明明，张嘉裕，张湘龙，等. 麦冬的化学成分和药理作用研究进展[J]. 中医药信息， 2020， 37(4):130-134.
    [25]
    严玉玲，万琼，周俭珊，等. 山慈菇抗肿瘤作用机制的研究进展[J]. 广东医学， 2016， 37 (22):3468-3469.
    [26]
    张瑜，郑作文. 八月札抗肿瘤作用的初步研究[J]. 广西中医药大学学报， 2016， 19(3): 9-10.
    [27]
    姜建伟，何福根，章红燕. 中药蜈蚣抗肿瘤作用机制及临床应用研究进展[J]. 海峡药学， 2012， 24(9):28-29.
    [28]
    程杏安，蒋旭红，刘展眉，等. 僵蚕七种化学成分抗肿瘤活性的初步研究[J]. 仲恺农业工程学院学报， 2015， 28(4):35-39.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (549) PDF downloads(463) Cited by()
    Proportional views
    Related

    Copyright © Journal of Nanjing University of traditional Chinese Medicine

    Sponsored by：Nanjing University of traditional Chinese MedicineAddress：No.138 xianlin Avenue, Qixia District, Nanjing cityChina Pos：210023

    Tel：025-85811935Email：xb@njucm.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return